Insight Molecular Diagnostics Inc. · NASDAQ:IMDX
Broadwood Capital Inc bought 182,861 Insight Molecular Diagnostics Inc. shares (Form 4)
Traded Apr 16 to Apr 20, 2026 · Filed Apr 20, 2026
From Apr 16 to Apr 20, 2026, Broadwood Capital Inc (10% owner) bought 182,861 Insight Molecular Diagnostics Inc. shares at an average US$3.57 for US$653K, leaving 12,114,700 shares. Filed Apr 20, 2026 (Form 4).
- Bought
- 182,861 shares
- Price
- US$3.57 average (US$3.45 to US$3.88)
- Value
- US$653K
- Holding after
- 12,114,700 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock, no par value | Buy | 102,057 | US$3.45 | 12,033,896 | Direct |
| Apr 16, 2026 | Common Stock, no par value | Buy | 0 | 12,033,896 | Indirect | |
| Apr 17, 2026 | Common Stock, no par value | Buy | 40,114 | US$3.57 | 12,074,010 | Direct |
| Apr 17, 2026 | Common Stock, no par value | Buy | 0 | 12,074,010 | Indirect | |
| Apr 20, 2026 | Common Stock, no par value | Buy | 40,690 | US$3.88 | 12,114,700 | Direct |
| Apr 20, 2026 | Common Stock, no par value | Buy | 0 | 12,114,700 | Indirect |